Louvain-la-Neuve, Belgium, January 25, 2018, 17.35 - IBA (Ion Beam Applications SA), the world`s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to ...
Louvain-la-Neuve, Belgium- March 20, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of radiopharmaceutical prod ...
ACQUISITION OF OWN SHARES Louvain-la-Neuve, Belgium, March 2nd, 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and ...
A conference call to discuss the trading update will be held today at 3pm CEST, 2pm BST, 9am EDT, details below. Louvain-La-Neuve, Belgium, July 5, 2017 - IBA (Ion Beam Applications S.A., EURONEXT), ...
Louvain-La-Neuve, Belgium, December 8, 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy ...
We have the honor of convening you to the Ordinary General Meeting (the "OGM") of IBA to be held on Wednesday June 11, 2025 at 10:00 A.M., to deliberate on the attached agenda. The OGM will be held in ...
Louvain-la-Neuve, Belgium, April 13, 2018, 17.35 - IBA (Ion Beam Applications SA), the world`s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue ...
IBA (Ion Beam Applications), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results